{
     "PMID": "12079687",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20030103",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "445",
     "IP": "3",
     "DP": "2002 Jun 12",
     "TI": "Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory.",
     "PG": "221-9",
     "AB": "The present study investigated the involvement of the serotonin (5-hydroxytryptamine, 5-HT) neuronal system in the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory in the eight-arm radial maze in rats. Delta(9)-Tetrahydrocannabinol (6 mg/kg, i.p.), which impairs spatial memory, significantly increased the 5-HT content in the ventral hippocampus. A microdialysis study showed that Delta(9)-tetrahydrocannabinol (6 mg/kg, i.p.) decreased 5-HT release in the ventral hippocampus. The 5-HT precursor, 5-hydroxy-L-tryptophan (5-HTP; 50 mg/kg, i.p.), the 5-HT re-uptake inhibitor, clomipramine (0.01 and 0.1 mg/kg, i.p.), the 5-HT receptor agonist, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT; 0.01 and 0.03 mg/kg, i.p.), and the 5-HT(2) receptor agonist, 1-(2,5-dimethoxy 4-iodophenyl)-2-amino propane (DOI; 10 microg/kg, i.p.), significantly attenuated the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. These results suggest that the 5-HT neuronal system may be involved in the Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory.",
     "FAU": [
          "Egashira, Nobuaki",
          "Mishima, Kenichi",
          "Katsurabayashi, Shutaro",
          "Yoshitake, Tomohiro",
          "Matsumoto, Yoshiaki",
          "Ishida, Junichi",
          "Yamaguchi, Masatoshi",
          "Iwasaki, Katsunori",
          "Fujiwara, Michihiro"
     ],
     "AU": [
          "Egashira N",
          "Mishima K",
          "Katsurabayashi S",
          "Yoshitake T",
          "Matsumoto Y",
          "Ishida J",
          "Yamaguchi M",
          "Iwasaki K",
          "Fujiwara M"
     ],
     "AD": "Department of Physiology and Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Serotonin Receptor Agonists)",
          "0 (Serotonin Uptake Inhibitors)",
          "333DO1RDJY (Serotonin)",
          "7J8897W37S (Dronabinol)",
          "C1LJO185Q9 (5-Hydroxytryptophan)"
     ],
     "SB": "IM",
     "MH": [
          "5-Hydroxytryptophan/pharmacology",
          "Animals",
          "Dronabinol/*pharmacology",
          "Hippocampus/drug effects/*metabolism",
          "Male",
          "Maze Learning/drug effects/physiology",
          "Memory/*drug effects/physiology",
          "Neurons/drug effects/*metabolism",
          "Rats",
          "Rats, Wistar",
          "Serotonin/*metabolism",
          "Serotonin Receptor Agonists/pharmacology",
          "Serotonin Uptake Inhibitors/pharmacology",
          "Spatial Behavior/drug effects/physiology"
     ],
     "EDAT": "2002/06/25 10:00",
     "MHDA": "2003/01/04 04:00",
     "CRDT": [
          "2002/06/25 10:00"
     ],
     "PHST": [
          "2002/06/25 10:00 [pubmed]",
          "2003/01/04 04:00 [medline]",
          "2002/06/25 10:00 [entrez]"
     ],
     "AID": [
          "S0014299902017557 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 2002 Jun 12;445(3):221-9.",
     "term": "hippocampus"
}